Literature DB >> 13926817

Reduction of tetramine toxicity by sedatives and anticonvulsants.

E VOSS, A R HASKELL, L GARTENBERG.   

Abstract

Entities:  

Keywords:  ANTICONVULSANTS/pharmacology; HETEROCYCLIC COMPOUNDS/toxicology; HYPNOTICS AND SEDATIVES/pharmacology

Mesh：

Substances：

Year:  1961        PMID： 13926817     DOI： 10.1002/jps.2600501014

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  10 in total

1.  Tetramethylenedisulphotetramine: an inhibitor of gamma-aminobutyric acid induced depolarization of the isolated superior cervical ganglion of the rat.

Authors:  N G Bowery; D A Brown; J F Collins
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

Review 2.  Tetramethylenedisulfotetramine neurotoxicity: What have we learned in the past 70 years?

Authors:  Marcela Lauková; Jana Velíšková; Libor Velíšek; Michael P Shakarjian
Journal:  Neurobiol Dis       Date:  2019-06-06       Impact factor: 5.996

3.  Differential antagonism of tetramethylenedisulfotetramine-induced seizures by agents acting at NMDA and GABA(A) receptors.

Authors:  Michael P Shakarjian; Jana Velíšková; Patric K Stanton; Libor Velíšek
Journal:  Toxicol Appl Pharmacol       Date:  2012-09-27       Impact factor: 4.219

4.  Characterization of seizures induced by acute and repeated exposure to tetramethylenedisulfotetramine.

Authors:  Dorota Zolkowska; Christopher N Banks; Ashish Dhir; Bora Inceoglu; James R Sanborn; Mark R McCoy; Donald A Bruun; Bruce D Hammock; Pamela J Lein; Michael A Rogawski
Journal:  J Pharmacol Exp Ther       Date:  2012-02-10       Impact factor: 4.030

5.  Behavioral intoxication following voluntary oral ingestion of tetramethylenedisulfotetramine: Dose-dependent onset, severity, survival, and recovery.

Authors:  Nathaniel C Rice; Noah A Rauscher; Jeffrey L Langston; Todd M Myers
Journal:  Neurotoxicology       Date:  2017-09-07       Impact factor: 4.294

6.  Tetramethylenedisulfotetramine alters Ca²⁺ dynamics in cultured hippocampal neurons: mitigation by NMDA receptor blockade and GABA(A) receptor-positive modulation.

Authors:  Zhengyu Cao; Bruce D Hammock; Mark McCoy; Michael A Rogawski; Pamela J Lein; Isaac N Pessah
Journal:  Toxicol Sci       Date:  2012-08-13       Impact factor: 4.849

7.  GABAA receptor target of tetramethylenedisulfotetramine.

Authors:  Chunqing Zhao; Sung Hee Hwang; Bruce A Buchholz; Timothy S Carpenter; Felice C Lightstone; Felice Lightstone; Jun Yang; Bruce D Hammock; John E Casida
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-27       Impact factor: 11.205

Review 8.  Tetramethylenedisulfotetramine: pest control gone awry.

Authors:  Michael P Shakarjian; Marcela Laukova; Jana Velíšková; Patric K Stanton; Diane E Heck; Libor Velíšek
Journal:  Ann N Y Acad Sci       Date:  2016-07-06       Impact factor: 5.691

9.  Bromide supplementation exacerbated the renal dysfunction, injury and fibrosis in a mouse model of Alport syndrome.

Authors:  Tsubasa Yokota; Kohei Omachi; Mary Ann Suico; Haruka Kojima; Misato Kamura; Keisuke Teramoto; Shota Kaseda; Jun Kuwazuru; Tsuyoshi Shuto; Hirofumi Kai
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

Review 10.  Tetramethylenedisulfotetramine: A Health Risk Compound and a Potential Chemical Warfare Agent.

Authors:  Jiří Patocka; Tanos C C Franca; Qinghua Wu; Kamil Kuca
Journal:  Toxics       Date:  2018-08-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.